Anavex Life Sciences (AVXL) is a publicly traded Healthcare sector company. As of September 8, 2026, AVXL trades at $2.84 with a market cap of $265.11M and a P/E ratio of -20.43. AVXL moved -1.92% today. Year to date, AVXL is -19.66%; over the trailing twelve months it is -69.57%. Its 52-week range spans $2.26 to $13.99. Rallies surfaces AVXL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for AVXL, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $2.84 |
| Market Cap | $265.11M |
| P/E Ratio | -20.43 |
| EPS | $-0.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.99 |
| 52-Week Low | $2.26 |
| Volume | 76.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.21M |
| Net Income | $-13.02M |
| Gross Margin | 0.00% |
AVXL analyst coverage data. Average price target: $0.00.